Cargando…
Novel therapeutic approaches for pulmonary fibrosis
Pulmonary fibrosis represents the end stage of a number of heterogeneous conditions and is, to a greater or lesser degree, the hallmark of the interstitial lung diseases. It is characterized by the excessive deposition of extracellular matrix proteins within the pulmonary interstitium leading to the...
Autores principales: | Datta, Arnab, Scotton, Chris J, Chambers, Rachel C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085875/ https://www.ncbi.nlm.nih.gov/pubmed/21265830 http://dx.doi.org/10.1111/j.1476-5381.2011.01247.x |
Ejemplares similares
-
Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis
por: Baliga, R S, et al.
Publicado: (2014) -
The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis
por: Platé, Manuela, et al.
Publicado: (2020) -
Enhancing natriuretic peptide bioactivity prevents bleomycin-induced pulmonary fibrosis
por: Baliga, Reshma S, et al.
Publicado: (2011) -
The Role of Herpes Viruses in Pulmonary Fibrosis
por: Duckworth, Anna, et al.
Publicado: (2021) -
Novel therapeutic approaches for the management of cystic fibrosis
por: Jaques, Ryan, et al.
Publicado: (2020)